Skip to content

US · HWKN · CHEMICALS - SPECIALTY

Hawkins, Inc. (HWKN) intrinsic value and stock valuation

$146.69as of 2026-11-21 · Mkt cap 2.82B

Data updated · price as of 2026-11-21

Strongly overvaluedIC value is more than 50% below the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Hawkins, Inc. DCF and intrinsic value

InvestorsCraft values HWKN with the Chepakovich two-stage DCF model — currently rated strongly overvalued. How the model works · Run your own DCF prefilled from HWKN’s statements →

Hawkins, Inc. Graham Number

Graham Number: $47.73d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →

Basic Materials · Chemicals - Specialty Roseville, MN 55113 hawkinsinc.com

How the business is doing

Fiscal 2012–2026, USD

Revenue
$1.08B+12.7% 5y CAGRd
20122026
Net income
$81.6M+14.8% 5y CAGRd
20122026
Free cash flow
$86.1M+30.2% 5y CAGRd
20122026
Total equity
$534M+15% 5y CAGRd
20122026

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2012–2026, USD
20262025202420232022
Revenue$1.08B$974.4M$919.2M$935.1M$774.5M
Operating income$115.1M$120.5M$104M$88.2M$71.2M
Net income$81.6M$84.3M$75.4M$60M$51.5M
EPSd$3.91M$4.03M$3.59M$2.86M$2.44M
Operating cash flow$144.3M$111.1M$159.5M$77.4M$42.8M
Capital expenditure-$-58.24M-$-41.1M-$-40.15M-$-48.32M-$-28.51M
Free cash flow$86.1M$70M$119.4M$29.1M$14.3M
Total assets$1B$769.9M$673.2M$602.4M$567.3M
Total debt$261.5M$162.6M$108.3M$120.3M$136.4M
Net debt$257.5M$157.5M$101.1M$112.8M$132.9M
Total equity$534M$460.3M$406M$350M$302.6M
Cash and short-term investments$3.91M$5.1M$7.15M$7.57M$3.5M
Income statement
20262025202420232022
Revenue$1.08B$974.4M$919.2M$935.1M$774.5M
Cost of revenue$859.9M$761.7M$725.5M$770M$628M
Gross profit$223.8M$212.7M$193.6M$165.1M$146.5M
Research and development expenses$0.00$0.00$0.00$0.00$0.00
Selling, general and administrative expenses$108.6M$92.2M$89.6M$77M$75.3M
Other expenses$0.00$0.00$0.00-$-330K$190K
Operating expenses$108.6M$92.2M$89.6M$77M$75.3M
Cost and expenses$968.6M$853.9M$815.1M$847M$703.4M
Interest income$0.00$0.00$0.00$0.00$0.00
Interest expense$13.5M$5.43M$4.28M$5.23M$1.4M
Depreciation and amortization$52.5M$40M$31.8M$29.4M$24.1M
Ebitda$175.4M$159.8M$137.2M$117.2M$95.5M
Operating income$115.1M$120.5M$104M$88.2M$71.2M
Total other income/expenses, net-$-5.78M-$-6.16M-$-2.89M-$-5.57M-$-1.22M
Income before tax$109.3M$114.4M$101.1M$82.6M$70M
Income tax expense$27.8M$30M$25.8M$22.5M$18.4M
Net income$81.6M$84.3M$75.4M$60M$51.5M
Weighted average shares outstanding$20.7M$20.8M$20.9M$20.9M$21M
Weighted average diluted shares outstanding$20.9M$20.9M$21M$21M$21.1M
Balance sheet
20262025202420232022
Cash and short-term investments$3.91M$5.1M$7.15M$7.57M$3.5M
Net receivables$140.7M$134.7M$114.5M$129.3M$122.8M
Inventory$78.2M$83.5M$74.6M$88.8M$95M
Total current assets$231.5M$230.7M$202.8M$232M$227.7M
Property, plant and equipment, net$283.1M$238.7M$220.6M$196M$172.5M
Goodwill and intangible assets$455.9M$285.5M$220M$150.5M$157.6M
Long-term investments$1.3M$2.4M$4.3M$4M$0.00
Total non-current assets$770.2M$539.2M$470.3M$370.3M$339.6M
Total assets$1B$769.9M$673.2M$602.4M$567.3M
Accounts payable$59.8M$61.2M$56.4M$53.7M$66.7M
Short-term debt$3M$12.8M$9.91M$9.91M$11.6M
Deferred revenue$1.58M$0.00$0.00$0.00$0.00
Total current liabilities$104.8M$107.1M$103.3M$90.9M$101.5M
Long-term debt$258.5M$149.8M$98.4M$110.4M$124.8M
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$362.8M$202.4M$163.8M$161.5M$163.3M
Capital lease obligations$17.5M$13.8M$9.53M$8.69M$10.8M
Total liabilities$467.7M$309.6M$267.1M$252.3M$264.7M
Common stock$210K$210K$210K$210K$210K
Retained earnings$500.1M$434.3M$364.6M$302.4M$254.4M
Accumulated other comprehensive income (loss)$980K$1.73M$3.12M$2.94M$1.29M
Total equity$534M$460.3M$406M$350M$302.6M
Total investments$1.3M$2.4M$4.3M$4M$0.00
Total debt$261.5M$162.6M$108.3M$120.3M$136.4M
Net debt$257.5M$157.5M$101.1M$112.8M$132.9M
Cash flow statement
20262025202420232022
Net income$81.6M$84.3M$75.4M$60M$51.5M
Depreciation and amortization$52.5M$40M$31.8M$27.4M$24.1M
Stock-based compensation$8.57M$6.5M$4.88M$3.83M$3.82M
Change in working capital$2.38M-$-24.39M$47M-$-13.12M-$-37.41M
Accounts receivable-$-2.47M-$-11.23M$21.4M-$-6.39M-$-30.53M
Inventory$10.1M-$-6.57M$19.9M$4.72M-$-30.03M
Accounts payable-$-5.84M$2.44M-$-830K-$-11.6M$25.1M
Net cash provided by operating activities$144.3M$111.1M$159.5M$77.4M$42.8M
Investments in property, plant and equipment-$-58.24M-$-41.1M-$-40.15M-$-48.32M-$-28.51M
Acquisitions, net-$-167.11M-$-87.4M-$-83.45M$0.00-$-21.55M
Net cash used for investing activities-$-224.1M-$-127.95M-$-122.5M-$-41.23M-$-49.76M
Common stock issued$3.04M$2.66M$2.24M$2.01M$1.77M
Common stock repurchased-$-3.03M-$-23.22M-$-13.41M-$-8.11M-$-10.01M
Dividends paid-$-15.66M-$-14.63M-$-13.24M-$-12M-$-11.06M
Net cash used for financing activities$78.6M$14.8M-$-37.41M-$-32.1M$7.42M
Net change in cash-$-1.19M-$-2.05M-$-410K$4.07M$500K
Cash at end of period$3.91M$5.1M$7.15M$7.57M$3.5M
Operating cash flow$144.3M$111.1M$159.5M$77.4M$42.8M
Capital expenditure-$-58.24M-$-41.1M-$-40.15M-$-48.32M-$-28.51M
Free cash flow$86.1M$70M$119.4M$29.1M$14.3M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Hawkins, Inc.

        Hawkins, Inc. is an enterprise engaged in the formulation, production, and distribution of chemicals and specialized ingredients, serving both domestic and international markets. Its operations are divided into three principal divisions: Industrial, Water Treatment, and Health and Nutrition. The Industrial division supplies industrial-grade chemicals, associated products, and services to a diverse array of sectors, including agriculture, chemical processing, electronics, energy, food production, pharmaceuticals, and plating. Key offerings encompass acids, alkaline compounds, and food-grade and pharmaceutical-quality salts and components. Furthermore, this segment manages the receipt, storage, and distribution of various bulk chemicals, such as liquid caustic soda, sulfuric acid, hydrochloric acid, urea, phosphoric acid, aqua ammonia, and potassium hydroxide. Manufacturing activities involve sodium hypochlorite, agricultural commodities, and a range of food-grade and pharmaceutical items like liquid phosphates, lactates, and custom blends. Additionally, the segment provides repackaging services for water treatment and bulk industrial chemicals, custom chemical blending, and contract and private-label packaging for bleach products. The Water Treatment division furnishes chemicals, equipment, and tailored solutions for applications in potable water, municipal and industrial wastewater management, industrial process water, and non-residential swimming pool and agricultural water systems. The Health and Nutrition division delivers ingredient procurement, processing, and formulation services to manufacturers specializing in nutraceuticals, functional foods and beverages, personal care items, dietary supplements, and other nutritional and health & wellness products. Its product portfolio features minerals, botanicals and herbal extracts, vitamins and amino acids, excipients, joint support products, sweeteners, and enzymes. The company, established in 1938, maintains its headquarters in Roseville, Minnesota.

        CEO
        Patrick H. Hawkins
        Employees
        1.2K
        Beta
        0.78

        Included in

        Explore

        Frequently asked questions

        What is the intrinsic value of Hawkins, Inc. (HWKN)?

        Hawkins, Inc. (HWKN) is currently strongly overvalued based on the InvestorsCraft IC model — IC value is more than 50% below the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is HWKN undervalued?

        HWKN trades at a price of $146.69 (Nov 21, 2026): strongly overvalued — IC value is more than 50% below the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.